Literature DB >> 19060223

The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension.

Eduardo Oliver1, Daniel Martí, Fermí Montó, Nicla Flacco, Lucrecia Moreno, Domingo Barettino, M Dolores Ivorra, Pilar D'Ocon.   

Abstract

In human and animal hypertension models, increased activity of G-protein-coupled receptor kinase (GRK) 2 determines a generalized decrease of beta-adrenergic vasodilatation. We analyzed the possibility of differential changes in the expression and functionality of alpha(1A), alpha(1B), alpha(1D), beta(1), beta(2), and beta(3)-ARs also being involved in the process. We combined the quantification of mRNA levels with immunoblotting and functional studies in aortas of young and adult spontaneously hypertensive rats (SHRs) and their controls (Wistar Kyoto). We found the expression and function of beta(1)-adrenoceptors in young prehypertensive SHRs to be higher, whereas a generalized increase in the expression of the six adrenoceptors and GRK2 was observed in aortas of adult hypertensive SHRs. alpha(1D)- and beta(3)-adrenoceptors, the subtypes that are more resistant to GRK2-mediated internalization and mostly expressed in rat aorta, exhibited an increased functional role in hypertensive animals, showing two hemodynamic consequences: 1) an increased sensitivity to the vasoconstrictor stimulus accompanied by a decreased sensitivity to the vasodilator stimulus (alpha(1D)-ARs are the most sensitive to agonists, and beta(3)-ARs are the least sensitive to agonists); and 2) a slower recovery of the basal tone after adrenergic stimulus removal because of the kinetic characteristic of the alpha(1D) subtype. These functional changes might be involved in the greater sympathetic vasoconstrictor tone observed in hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060223     DOI: 10.1124/jpet.108.146043

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies.

Authors:  Chantal Gauthier; Bertrand Rozec; Boris Manoury; Jean-Luc Balligand
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion.

Authors:  S Martínez-Revelles; L Caracuel; A Márquez-Martín; Ap Dantas; E Oliver; P D'Ocon; E Vila
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 3.  G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.

Authors:  Stephen L Belmonte; Burns C Blaxall
Journal:  Circ Res       Date:  2011-07-22       Impact factor: 17.367

4.  Alpha(1D)-adrenergic receptor insensitivity is associated with alterations in its expression and distribution in cultured vascular myocytes.

Authors:  Lin-lin Fan; Shuang Ren; Hong Zhou; Ying Wang; Ping-xiang Xu; Jun-qi He; Da-li Luo
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

5.  Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Authors:  N Flacco; V Segura; M Perez-Aso; S Estrada; J F Seller; F Jiménez-Altayó; M A Noguera; P D'Ocon; E Vila; M D Ivorra
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals.

Authors:  Eric Secemsky; David Lange; David D Waters; Nora F Goldschlager; Priscilla Y Hsue
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-16       Impact factor: 3.738

Review 7.  G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure.

Authors:  Jian Yang; Van Anthony M Villar; Ines Armando; Pedro A Jose; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-07-07       Impact factor: 5.501

8.  Differences in the signaling pathways of α(1A)- and α(1B)-adrenoceptors are related to different endosomal targeting.

Authors:  Vanessa Segura; Miguel Pérez-Aso; Fermí Montó; Elena Carceller; María Antonia Noguera; John Pediani; Graeme Milligan; Ian Christie McGrath; Pilar D'Ocon
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

9.  The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology.

Authors:  Tijana Bojic; Emina Sudar; Dimitri Mikhailidis; Dragan Alavantic; Esma Isenovic
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

10.  Role of adenylyl cyclase in reduced β-adrenoceptor-mediated vasorelaxation during maturation.

Authors:  O A López-Canales; M C Castillo-Hernandez; H Vargas-Robles; A Rios; J S López-Canales; B Escalante
Journal:  Braz J Med Biol Res       Date:  2016-07-04       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.